Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilesh Kumar

Showing results (21-30 of 335) with videos related to

Pageof 34
Sort By:
Applied Optics|August 12, 2025
Metasurface-loaded silicon-graphene composite twin-port THz radiator with pattern diversity and circular polarization featuresNilesh Kumar, Sangeeta Kumari, Arvind Kumar
Nano Letters|November 14, 2025
Stacking-Dependent Interlayer Excitons in BP/CrSe<sub>2</sub> van der Waals HeterostructureNilesh Kumar, Miroslav Kolos, František Karlický
Acta Diabetologica|October 5, 2024
Obese have comparable ankle brachial pressure index but higher β-cell function and insulin resistance as compared to normal-weight type 2 diabetes mellitus patientsUmashree Yadav, Nilesh Kumar, Kumar Sarvottam
Frontiers in Artificial Intelligence|August 10, 2023
Artificial intelligence vs. evolving super-complex tumor intelligence: critical viewpointsNilesh Kumar Sharma, Sachin C Sarode
Infectious Disorders Drug Targets|May 4, 2022
Demographic, Clinical, and Investigational Characteristics of COVID-19- related Guillain-Barré Syndrome with Differences from Typical and Another Virus-related Guillain-Barré SyndromeJitendra Singh, Nilesh Kumar, Anju Dinkar
Chinese Medical Journal|November 28, 2015
Paraparesis in Coarctation of Aorta: Diagnosis in DisguiseAnup Singh, Annesh Bhattacharya, Nilesh Kumar
Ophthalmology|March 2, 2021
Re: Kunimoto et al.: Efficacy and safety of abicipar in neovascular age-related macular degeneration: 52-week results of phase 3 randomized controlled study (Ophthalmology. 2020:127:1331-1334)Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri
Ophthalmology|November 25, 2019
Re: Dugel et al: HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration (Ophthalmology. 2019 Apr 12 [Epub ahead of print])Ashish Sharma, Nilesh Kumar, Francesco Bandello
Cancers|November 9, 2024
Evolving Artificial Intelligence (AI) at the Crossroads: Potentiating Productive vs. Declining Disruptive Cancer ResearchNilesh Kumar Sharma, Sachin C Sarode
Nanotechnology|October 21, 2021
Strain tailored thermodynamic stability, electronic transitions, and optoelectronic properties of III (In, Ga and Al)-nitride monolayersNilesh Kumar, Rajneesh Chaurasiya, Ambesh Dixit
Pageof 34

Showing results (21-30 of 335) with videos related to

Sort By:
Pageof 34
Applied Optics|August 12, 2025
Metasurface-loaded silicon-graphene composite twin-port THz radiator with pattern diversity and circular polarization featuresNilesh Kumar, Sangeeta Kumari, Arvind Kumar
Nano Letters|November 14, 2025
Stacking-Dependent Interlayer Excitons in BP/CrSe<sub>2</sub> van der Waals HeterostructureNilesh Kumar, Miroslav Kolos, František Karlický
Acta Diabetologica|October 5, 2024
Obese have comparable ankle brachial pressure index but higher β-cell function and insulin resistance as compared to normal-weight type 2 diabetes mellitus patientsUmashree Yadav, Nilesh Kumar, Kumar Sarvottam
Frontiers in Artificial Intelligence|August 10, 2023
Artificial intelligence vs. evolving super-complex tumor intelligence: critical viewpointsNilesh Kumar Sharma, Sachin C Sarode
Infectious Disorders Drug Targets|May 4, 2022
Demographic, Clinical, and Investigational Characteristics of COVID-19- related Guillain-Barré Syndrome with Differences from Typical and Another Virus-related Guillain-Barré SyndromeJitendra Singh, Nilesh Kumar, Anju Dinkar
Chinese Medical Journal|November 28, 2015
Paraparesis in Coarctation of Aorta: Diagnosis in DisguiseAnup Singh, Annesh Bhattacharya, Nilesh Kumar
Ophthalmology|March 2, 2021
Re: Kunimoto et al.: Efficacy and safety of abicipar in neovascular age-related macular degeneration: 52-week results of phase 3 randomized controlled study (Ophthalmology. 2020:127:1331-1334)Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri
Ophthalmology|November 25, 2019
Re: Dugel et al: HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration (Ophthalmology. 2019 Apr 12 [Epub ahead of print])Ashish Sharma, Nilesh Kumar, Francesco Bandello
Cancers|November 9, 2024
Evolving Artificial Intelligence (AI) at the Crossroads: Potentiating Productive vs. Declining Disruptive Cancer ResearchNilesh Kumar Sharma, Sachin C Sarode
Nanotechnology|October 21, 2021
Strain tailored thermodynamic stability, electronic transitions, and optoelectronic properties of III (In, Ga and Al)-nitride monolayersNilesh Kumar, Rajneesh Chaurasiya, Ambesh Dixit
Pageof 34